Investing in new medicines pays for itself: report

A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modeling, published in The impact of pharmaceutical innovation on premature mortality, hospital separations, and cancer survival in Australia, was conducted by American economist Professor Frank Lichtenberg. “This comprehensive study shows that taxpayers and patients are